These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

88 related articles for article (PubMed ID: 8395713)

  • 1. Prophylaxis of embolic events in patients with atrial fibrillation using low molecular weight heparin.
    Harenberg J; Weuster B; Pfitzer M; Dempfle CE; Stehle G; Kübler W; Schlierf G
    Semin Thromb Hemost; 1993; 19 Suppl 1():116-21. PubMed ID: 8395713
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Anticoagulation with the low-molecular-weight heparin dalteparin (Fragmin) in atrial fibrillation and TEE-guided cardioversion.
    Bechtold H; Gunzenhauser D; Sawitzki H; Fung S; Janssen D
    Z Kardiol; 2003 Jul; 92(7):532-9. PubMed ID: 12883837
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Embolic events in 93 elderly Chinese patients with atrial fibrillation.
    Cao X; Wang S; Jiang L; Liu L; Huang H; Lu Z
    Chin Med J (Engl); 2000 Apr; 113(4):320-3. PubMed ID: 11775227
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Long-term anticoagulation of outpatients with adverse events to oral anticoagulants using low-molecular-weight heparin.
    Harenberg J; Huhle G; Piazolo L; Giese C; Heene DL
    Semin Thromb Hemost; 1997; 23(2):167-72. PubMed ID: 9200342
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long term anticoagulation with low molecular weight heparin in outpatients with side effects on oral anticoagulants.
    Harenberg J; Leber G; Dempfle CE; Heene DL; Zimmermann R; Kübler W
    Nouv Rev Fr Hematol (1978); 1989; 31(5):363-9. PubMed ID: 2555770
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Monitored atrial fibrillation duration predicts arterial embolic events in patients suffering from bradycardia and atrial fibrillation implanted with antitachycardia pacemakers.
    Capucci A; Santini M; Padeletti L; Gulizia M; Botto G; Boriani G; Ricci R; Favale S; Zolezzi F; Di Belardino N; Molon G; Drago F; Villani GQ; Mazzini E; Vimercati M; Grammatico A;
    J Am Coll Cardiol; 2005 Nov; 46(10):1913-20. PubMed ID: 16286180
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Long-term fate of left atrial thrombi and incidence of cerebral embolism under continuous anticoagulation therapy].
    Strach K; Meyer C; Hackenbroch M; Tiemann K; Haase J; Pizulli L; Omran H; Schild H; Sommer T
    Rofo; 2005 Dec; 177(12):1706-12. PubMed ID: 16333795
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A multicenter randomized double-blind study of enoxaparin compared with unfractionated heparin in the prevention of venous thromboembolic disease in elderly in-patients bedridden for an acute medical illness. The Enoxaparin in Medicine Study Group.
    Bergmann JF; Neuhart E
    Thromb Haemost; 1996 Oct; 76(4):529-34. PubMed ID: 8902991
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical outcomes with unfractionated heparin or low-molecular-weight heparin as bridging therapy in patients on long-term oral anticoagulants: the REGIMEN registry.
    Spyropoulos AC; Turpie AG; Dunn AS; Spandorfer J; Douketis J; Jacobson A; Frost FJ;
    J Thromb Haemost; 2006 Jun; 4(6):1246-52. PubMed ID: 16706967
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prevention of perioperative thromboembolism in patients with atrial fibrillation.
    Beldi G; Beng L; Siegel G; Bisch-Knaden S; Candinas D
    Br J Surg; 2007 Nov; 94(11):1351-5. PubMed ID: 17631677
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of six-month outcome of patients initially treated for acute deep vein thrombosis with a low molecular weight heparin Certoparin at a fixed, body-weight-independent dosage or unfractionated heparin.
    Harenberg J; Riess H; Büller HR; Brom J; Weidinger G; Huisman MV
    Haematologica; 2003 Oct; 88(10):1157-62. PubMed ID: 14555312
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A comparative double-blind, randomised trial of a new second generation LMWH (bemiparin) and UFH in the prevention of post-operative venous thromboembolism. The Bemiparin Assessment group.
    Kakkar VV; Howes J; Sharma V; Kadziola Z
    Thromb Haemost; 2000 Apr; 83(4):523-9. PubMed ID: 10780310
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Patients at high risk with atrial fibrillation: a prospective and serial follow-up during 12 months with transesophageal echocardiography and cerebral magnetic resonance imaging.
    Bernhardt P; Schmidt H; Hammerstingl C; Lüderitz B; Omran H
    J Am Soc Echocardiogr; 2005 Sep; 18(9):919-24. PubMed ID: 16153514
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Safety and efficacy of enoxaparin compared with unfractionated heparin and oral anticoagulants for prevention of thromboembolic complications in cardioversion of nonvalvular atrial fibrillation: the Anticoagulation in Cardioversion using Enoxaparin (ACE) trial.
    Stellbrink C; Nixdorff U; Hofmann T; Lehmacher W; Daniel WG; Hanrath P; Geller C; Mügge A; Sehnert W; Schmidt-Lucke C; Schmidt-Lucke JA;
    Circulation; 2004 Mar; 109(8):997-1003. PubMed ID: 14967716
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Anticoagulant and/or antiplatelet treatment in patients with atrial fibrillation after percutaneous coronary intervention. A single-center experience.
    Maegdefessel L; Schlitt A; Faerber J; Bond SP; Messow CM; Buerke M; Raaz U; Werdan K; Muenzel T; Weiss C
    Med Klin (Munich); 2008 Sep; 103(9):628-32. PubMed ID: 18813885
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Low-molecular-weight heparin as bridging anticoagulation during interruption of warfarin: assessment of a standardized periprocedural anticoagulation regimen.
    Douketis JD; Johnson JA; Turpie AG
    Arch Intern Med; 2004 Jun; 164(12):1319-26. PubMed ID: 15226166
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Cardiac rhythm and systemic embolism in long-term follow up of patients with non-valvular paroxysmal atrial fibrillation].
    Bugueño C; Corbalán R; Braun S; Tapia J; Kramer A; Huete I; Chávez A
    Rev Med Chil; 1998 Jun; 126(6):646-54. PubMed ID: 9778872
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Low-molecular-weight heparin (LMWH) in the treatment of thrombosis.
    Holzheimer RG
    Eur J Med Res; 2004 Apr; 9(4):225-39. PubMed ID: 15210403
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Embolic episodes after treatment of atrial fibrillation in a patient with thyrotoxicosis].
    Hendriksen O; Petersen CL
    Ugeskr Laeger; 1995 Jul; 157(29):4138-9. PubMed ID: 7652995
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Embolism and atrial fibrillation. A longitudinal follow-up.
    Yipintsoi T; Jirathamopas W; Suntiparpluacha C; Jintapakorn W; Akaravinake A; Kunjara-Na-Ayudhya R
    J Med Assoc Thai; 1992 Feb; 75(2):73-8. PubMed ID: 1645052
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.